321 related articles for article (PubMed ID: 37511507)
21. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
[TBL] [Abstract][Full Text] [Related]
22. P2X7-deficiency improves plasticity and cognitive abilities in a mouse model of Tauopathy.
Carvalho K; Martin E; Ces A; Sarrazin N; Lagouge-Roussey P; Nous C; Boucherit L; Youssef I; Prigent A; Faivre E; Eddarkaoui S; Gauvrit T; Vieau D; Boluda S; Huin V; Fontaine B; Buée L; Delatour B; Dutar P; Sennlaub F; Guillonneau X; Blum D; Delarasse C;
Prog Neurobiol; 2021 Nov; 206():102139. PubMed ID: 34391810
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
Zhang Y; Zhao Y; Zhang J; Yang G
Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
[TBL] [Abstract][Full Text] [Related]
24. P2X7 receptor-pannexin 1 interaction mediates extracellular alpha-synuclein-induced ATP release in neuroblastoma SH-SY5Y cells.
Wilkaniec A; Gąssowska M; Czapski GA; Cieślik M; Sulkowski G; Adamczyk A
Purinergic Signal; 2017 Sep; 13(3):347-361. PubMed ID: 28516276
[TBL] [Abstract][Full Text] [Related]
25. Regulation of P2X7 receptor expression and function in the brain.
Jimenez-Mateos EM; Smith J; Nicke A; Engel T
Brain Res Bull; 2019 Sep; 151():153-163. PubMed ID: 30593878
[TBL] [Abstract][Full Text] [Related]
26. Aβ
Dias L; Madeira D; Dias R; Tomé ÂR; Cunha RA; Agostinho P
Cell Mol Life Sci; 2022 Jul; 79(8):457. PubMed ID: 35907034
[TBL] [Abstract][Full Text] [Related]
27. The P2X7-Egr pathway regulates nucleotide-dependent inflammatory gene expression in microglia.
Friedle SA; Brautigam VM; Nikodemova M; Wright ML; Watters JJ
Glia; 2011 Jan; 59(1):1-13. PubMed ID: 20878769
[TBL] [Abstract][Full Text] [Related]
28. Purinergic receptors as potential therapeutic targets in Alzheimer's disease.
Woods LT; Ajit D; Camden JM; Erb L; Weisman GA
Neuropharmacology; 2016 May; 104():169-79. PubMed ID: 26519903
[TBL] [Abstract][Full Text] [Related]
29. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
[TBL] [Abstract][Full Text] [Related]
30. Actin-mediated Microglial Chemotaxis via G-Protein Coupled Purinergic Receptor in Alzheimer's Disease.
Das R; Chinnathambi S
Neuroscience; 2020 Nov; 448():325-336. PubMed ID: 32941933
[TBL] [Abstract][Full Text] [Related]
31. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
Yang J; Wise L; Fukuchi KI
Front Immunol; 2020; 11():724. PubMed ID: 32391019
[TBL] [Abstract][Full Text] [Related]
32. Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets.
Cai Y; Liu J; Wang B; Sun M; Yang H
Front Immunol; 2022; 13():856376. PubMed ID: 35558075
[TBL] [Abstract][Full Text] [Related]
33. Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome.
Wang W; Hu D; Feng Y; Wu C; Song Y; Liu W; Li A; Wang Y; Chen K; Tian M; Xiao F; Zhang Q; Chen W; Pan P; Wan P; Liu Y; Lan H; Wu K; Wu J
BMC Biol; 2020 Nov; 18(1):182. PubMed ID: 33243234
[TBL] [Abstract][Full Text] [Related]
34. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
[TBL] [Abstract][Full Text] [Related]
35. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
[TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
37. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
38. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
Hickman SE; Allison EK; El Khoury J
J Neurosci; 2008 Aug; 28(33):8354-60. PubMed ID: 18701698
[TBL] [Abstract][Full Text] [Related]
39. Selective upregulation of Per1 mRNA expression by ATP through activation of P2X7 purinergic receptors expressed in microglial cells.
Nakazato R; Takarada T; Yamamoto T; Hotta S; Hinoi E; Yoneda Y
J Pharmacol Sci; 2011; 116(4):350-61. PubMed ID: 21747211
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's amyloid-β peptide disturbs P2X7 receptor-mediated circadian oscillations of intracellular calcium.
Wilkaniec A; Schmitt K; Grimm A; Strosznajder JB; Eckert A
Folia Neuropathol; 2016; 54(4):360-368. PubMed ID: 28139817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
